Registry for individuals with type 1 diabetes in Canada
Registry of Individuals With Type 1 Diabetes Living in Canada: The BETTER Registry
This study is gathering information from people with type 1 diabetes in Canada to learn more about their experiences with low blood sugar episodes and how it affects their lives.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6000 (estimated) |
| Sex | All |
| Sponsor | Institut de Recherches Cliniques de Montreal Academic / other |
| Locations | 7 sites (Edmonton, Alberta and 6 other locations) |
| Trial ID | NCT03720197 on ClinicalTrials.gov |
What this trial studies
This registry aims to gather comprehensive data on individuals living with type 1 diabetes in Canada, focusing on the frequency and severity of hypoglycemic episodes. Participants will complete questionnaires regarding their experiences with hypoglycemia, including symptoms, fears, and contributing factors such as insulin therapy and nutrition. The study is divided into three phases, with the first phase mandatory for all participants, while the subsequent phases are optional and involve additional data collection, including blood tests and lifestyle assessments. The goal is to create a detailed profile of the type 1 diabetes population in Canada and understand the implications of hypoglycemia.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals diagnosed with type 1 diabetes who reside in Canada.
Not a fit: Patients with type 2 diabetes or gestational diabetes will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of hypoglycemia in type 1 diabetes, leading to improved management strategies for patients.
How similar studies have performed: While similar registries have been established, this specific approach focusing on hypoglycemia in type 1 diabetes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of type 1 diabetes * Living in Canada Exclusion Criteria: * Type 2 diabetes * Gestational diabetes
Where this trial is running
Edmonton, Alberta and 6 other locations
- Alberta Diabetes Institute — Edmonton, Alberta, Canada (Recruiting)
- Institut de recherches cliniques de Montréal — Montreal, Quebec, Canada (Recruiting)
- Centre Hospitalier de l'Université de Montréal — Montreal, Quebec, Canada (Recruiting)
- Centre Hospitalier Universitaire Sainte-Justine — Montreal, Quebec, Canada (Recruiting)
- McGill University Health Centre — Montreal, Quebec, Canada (Recruiting)
- Centre Hospitalier Universitaire de Québec-Université Laval — Québec, Quebec, Canada (Recruiting)
- Centre hospitalier universitaire de Sherbrooke — Sherbrooke, Quebec, Canada (Recruiting)
Study contacts
- Principal investigator: Remi Rabasa-Lhoret — Institut de recherches cliniques de Montréal
- Study coordinator: Virginie Messier
- Email: virginie.messier@ircm.qc.ca
- Phone: 514-987-5500
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.